Clinical Trial Update: Evaluation of a New Formulation Useful for the Osteoarthrosis Treatment [Phase 2, Phase 3]

View source ↗

Summary

This document notes an evaluation of a new formulation for osteoarthritis in Phase 2 and Phase 3 trials; no trial results or status information are provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Snippet

Sponsor: Nucitec | Conditions: Osteoarthritis | Phase 2, Phase 3 | Status: UNKNOWN